| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $69.9M | +19.4% |
| SG&A Expense | $16.3M | -39.3% |
| Operating Income | -$86.2M | -0.9% |
| Pre-tax Income | -$79.9M | -6.8% |
| Income Tax | -$2.2M | +86.5% |
| Net Income | -$77.7M | -32.4% |
| EPS (Basic) | -$1.48 | -29.8% |
| EPS (Diluted) | -$1.48 | -29.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.0M | -7.1% |
| Short-term Investments | $75.0M | -41.7% |
| Current Assets | $115.2M | -34.4% |
| Total Assets | $116.6M | -39.1% |
| Current Liabilities | $11.4M | -20.6% |
| Total Liabilities | $11.8M | -22.1% |
| Stockholders' Equity | $104.7M | -40.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.6M | -43.5% |
| Capital Expenditures | $29K | -95.6% |
| Investing Cash Flow | $70.2M | +31.5% |
| Financing Cash Flow | $505K | +61.3% |
| Free Cash Flow | -$73.6M | -41.7% |